These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37369465)

  • 21. Unlocking the Role of Endothelial MPL Receptor and JAK2V617F Mutation: Insights into Cardiovascular Dysfunction in MPNs and CHIP.
    Zhang H; Kafeiti N; Lee S; Masarik K; Zheng H; Zhan H
    bioRxiv; 2023 Jul; ():. PubMed ID: 37503259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the Clinical Significance of JAK2V617F Allele Burden in Philadelphia Chromosome-Negative Myeloproliferative Neoplasm.
    Chen P; Ouyang J; Liang J; Yu X; Huang B
    Clin Lab; 2016 Aug; 62(8):1477-1481. PubMed ID: 28164603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells.
    Mitsumori T; Nozaki Y; Kawashima I; Yamamoto T; Shobu Y; Nakajima K; Morishita S; Komatsu N; Kirito K
    Exp Hematol; 2014 Sep; 42(9):783-92.e1. PubMed ID: 24860972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm.
    Poisson J; Tanguy M; Davy H; Camara F; El Mdawar MB; Kheloufi M; Dagher T; Devue C; Lasselin J; Plessier A; Merchant S; Blanc-Brude O; Souyri M; Mougenot N; Dingli F; Loew D; Hatem SN; James C; Villeval JL; Boulanger CM; Rautou PE
    J Clin Invest; 2020 May; 130(5):2630-2643. PubMed ID: 32045382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Murine Model With JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm.
    Zhang H; Yeware A; Lee S; Zhan H
    Front Oncol; 2021; 11():753465. PubMed ID: 34765558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine 201 is required for constitutive activation of JAK2V617F and efficient induction of myeloproliferative disease in mice.
    Yan D; Hutchison RE; Mohi G
    Blood; 2012 Aug; 120(9):1888-98. PubMed ID: 22837531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.
    Dentali F; Squizzato A; Brivio L; Appio L; Campiotti L; Crowther M; Grandi AM; Ageno W
    Blood; 2009 May; 113(22):5617-23. PubMed ID: 19273837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The thrombopoietin receptor, MPL, is critical for development of a JAK2V617F-induced myeloproliferative neoplasm.
    Sangkhae V; Etheridge SL; Kaushansky K; Hitchcock IS
    Blood; 2014 Dec; 124(26):3956-63. PubMed ID: 25339357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JAK2
    Lin CH; Kaushansky K; Zhan H
    Blood Cells Mol Dis; 2016 Nov; 62():42-48. PubMed ID: 27865175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel, highly sensitive and rapid allele-specific loop-mediated amplification assay for the detection of the JAK2V617F mutation in chronic myeloproliferative neoplasms.
    Minnucci G; Amicarelli G; Salmoiraghi S; Spinelli O; Guinea Montalvo ML; Giussani U; Adlerstein D; Rambaldi A
    Haematologica; 2012 Sep; 97(9):1394-400. PubMed ID: 22315499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress of study on JAK2V617F mutation in myeloproliferative neoplasm].
    Chen YX; Li Y; Zhang LY; Liu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1329-33. PubMed ID: 22040998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a highly sensitive method for detection of JAK2V617F.
    Zhao AH; Gao R; Zhao ZJ
    J Hematol Oncol; 2011 Oct; 4():40. PubMed ID: 21985400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cigarette smoke extract and nicotine on the expression of thrombomodulin and endothelial protein C receptor in cultured human umbilical vein endothelial cells.
    Wei Y; Lai B; Liu H; Li Y; Zhen W; Fu L
    Mol Med Rep; 2018 Jan; 17(1):1724-1730. PubMed ID: 29257196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic JAK2V617F requires an intact SH2-like domain for constitutive activation and induction of a myeloproliferative disease in mice.
    Gorantla SP; Dechow TN; Grundler R; Illert AL; Zum Büschenfelde CM; Kremer M; Peschel C; Duyster J
    Blood; 2010 Nov; 116(22):4600-11. PubMed ID: 20696946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
    Sankar K; Stein BL; Rampal RK
    Cancer Treat Res; 2019; 179():159-178. PubMed ID: 31317487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crucial role of hematopoietic
    Yokokawa T; Misaka T; Kimishima Y; Wada K; Minakawa K; Sugimoto K; Ishida T; Morishita S; Komatsu N; Ikeda K; Takeishi Y
    Haematologica; 2021 Jul; 106(7):1910-1922. PubMed ID: 33567809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regulation of Ruxolitinib on matrix metalloproteinase in JAK2V617F positive myeloroliferative neoplasms cells].
    Liu GM; Zhang LJ; Fu JZ; Liang WT; Cheng ZY; Bai P; Bian YS; Wan JS
    Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):140-145. PubMed ID: 28279039
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac hypertrophy associated with myeloproliferative neoplasms in JAK2V617F transgenic mice.
    Shi K; Zhao W; Chen Y; Ho WT; Yang P; Zhao ZJ
    J Hematol Oncol; 2014 Mar; 7():25. PubMed ID: 24646493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.
    Misawa K; Yasuda H; Araki M; Ochiai T; Morishita S; Shirane S; Edahiro Y; Gotoh A; Ohsaka A; Komatsu N
    Int J Hematol; 2018 Jun; 107(6):673-680. PubMed ID: 29464483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.